The independent source for health policy research, polling, and news.
261 - 280 of 759 Results
Industry analysts are skeptical that Federal Trade Commission Chair Lina Khan can win her first fight against a drug industry merger. It will be reviewed by a judge appointed by then-President Donald Trump.
A three-judge appeals court panel heard testimony this week about revoking the FDA鈥檚 22-year-old approval of a key pill used in medication abortion and miscarriage management. The judges all have track records of siding with abortion foes. Meanwhile, as the standoff over raising the federal debt ceiling continues in Washington, a major sticking point is whether to impose work requirements on recipients of Medicaid coverage. Victoria Knight of Axios, Rachel Roubein of The Washington Post, and Sandhya Raman of CQ Roll Call join 吃瓜不打烊 chief Washington correspondent Julie Rovner to discuss these issues and more.
The 5th Circuit Court of Appeals in New Orleans heard oral arguments Wednesday in a case brought by conservative Christian abortion opponents seeking to revoke FDA approval of mifepristone, a medication used in more than half of abortions in the U.S.
The Camp Lejeune Justice Act, which became law last year, created a pathway for veterans and their families to pursue damage claims against the government for toxic exposure at the military base. Now, advocates and lawmakers worry high lawyer fees could shortchange those injured.
The lawyer for an emergency physicians group says its lawsuit against Envision Healthcare should be allowed to proceed even though the company has filed for Chapter 11 protection.
Laws granting rights to unborn children have spread in the decades since the U.S. and Missouri supreme courts allowed Missouri鈥檚 definition of life as beginning at conception to stand. Now, a wrongful death lawsuit involving a workplace accident shows how sprawling those laws 鈥 often intended to curb abortion 鈥 have become.
A warning from the Treasury Department that the U.S. could default on its debt as soon as June 1 has galvanized lawmakers to intervene. But there is still no obvious way to reconcile Republican demands to slash federal spending with President Joe Biden鈥檚 demand to raise the debt ceiling and save the spending fight for a later date. Meanwhile, efforts to pass abortion bans in conservative states are starting to stall as some Republicans rebel against the most severe bans. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Cohrs of Stat, and Alice Miranda Ollstein of Politico join 吃瓜不打烊 chief Washington correspondent Julie Rovner to discuss these issues and more.
吃瓜不打烊 and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.
Disability rights advocates and two individuals with disabilities sued Tuesday to overturn the state's physician-assisted death law, arguing it is unconstitutional, violates the Americans with Disabilities Act, and makes it too easy for people with terminal diseases whose deaths aren't imminent to kill themselves with a doctor's help.
The Supreme Court on April 21 ruled that the abortion pill mifepristone should remain widely available while the lower courts consider the issue, blocking earlier rulings that banned or restricted access to the drug. 吃瓜不打烊鈥 Julie Rovner joined NPR鈥檚 鈥淲eekend All Things Considered鈥 to discuss the complicated case.
The Supreme Court is considering the future of the abortion pill mifepristone, after GenBioPro sued the FDA over limitations that effectively block generic production of the drug, a major part of the market. Congress is considering proposals that would impose Medicaid work requirements, crack down on pharmacy benefit managers, and more. And President Joe Biden moved to expand health coverage to young immigrants known as 鈥淒reamers.鈥 Rachel Cohrs of Stat, Sandhya Raman of CQ Roll Call, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join 吃瓜不打烊鈥 Mary Agnes Carey to discuss these issues and more.
Lisa French was told her surgery would cost $1,337. But the hospital sent her a bill for $229,000, then sued her. The case went all the way to the Colorado Supreme Court. The court鈥檚 ruling could have major implications for determining a 鈥渞easonable price鈥 in health care.
The legality and availability of the abortion pill mifepristone is in question after a federal judge in Texas canceled the FDA鈥檚 approval of the first drug used in the two-drug medication abortion regimen. A 5th Circuit Court of Appeals panel overruled that decision in part, saying the pill should remain available, but only under the onerous restrictions in place before 2016. Meanwhile, another federal judge in Washington state issued a ruling in a separate case that conflicts with the Texas decision, ordering the FDA not to roll back any of its restrictions on the drug. Victoria Knight of Axios, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join 吃瓜不打烊 chief Washington correspondent Julie Rovner to discuss these issues and more.
The American Medical Association ducked the abortion issue for years and now sees its members鈥 professional opinions second-guessed by lawmakers and judges. PhRMA is following the same playbook.
A federal judge鈥檚 recent ruling on the Affordable Care Act is by no means the final word. Even parsing its impact is complicated. Here are key issues to watch as the case works its way through the legal system.
A U.S. District Court ruling overturned the section of the Affordable Care Act that makes preventive health services 鈥 from colonoscopies to diabetes screenings and more 鈥 available at no cost to consumers.
A year after private equity-backed Noble Health shuttered two rural Missouri hospitals, a slew of lawsuits and state and federal investigations grind forward. Missouri Attorney General Andrew Bailey recently confirmed an 鈥渙ngoing鈥 investigation as former employees continue to go unpaid and cope with unpaid medical claims.
A U.S. District Court case is being widely followed because the judge鈥檚 decision could overturn the FDA鈥檚 approval of mifepristone two decades ago. With abortion rights polling well even in red states, anti-abortion activists are increasingly turning to the courts to achieve their aims.
A state law says giving false information to patients about covid-19 constitutes unprofessional conduct for which regulators can discipline doctors. Vaccine skeptics, including Robert F. Kennedy Jr., join civil liberties groups and others in arguing that it violates free speech.
Any day now a conservative federal judge in Texas could upend the national abortion debate by requiring the FDA to rescind its approval of mifepristone, a drug approved in the U.S. more than 20 years ago that is now used in more than half of abortions nationwide. Meanwhile, a controversial study on masks gets a clarification, although it may be too late to change the public impression of what it found. Alice Miranda Ollstein of Politico, Jessie Hellmann of CQ Roll Call, and Sarah Karlin-Smith of the Pink Sheet join KHN chief Washington correspondent Julie Rovner to discuss these issues and more. Plus, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week they think you should read, too.
漏 2026 KFF